Top Markets
#1 Wibx Wibx +8.04%
#2 Status Status +7.37%
#3 Decred Decred +5.88%
#4 aelf aelf +5.49%
#5 Humanity Humanity +4.81%
#6 SkyAI SkyAI +4.75%
#7 Robinhood Wrapped ETH (Robinhood Chain) Robinhood Wrapped ETH (Robinhood Chain) +3.86%
#8 MarsCoin MarsCoin +3.34%
#9 TRIA TRIA +3.25%
#10 OpenServ OpenServ +2.94%
Coin of the day
Wibx Wibx
설정
언어
한국어
통화
USD
테마
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
주식 순위 #30680
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
주가
$0.91968646
마지막 동기화: 2026-08-18
시가총액
$15.91M
변동 (1일)
2.23%
변동 (1년)
-52.75%
국가
KR
거래 Xcell Therapeutics, Inc. (373110)

카테고리

Healthcare
Xcell Therapeutics, Inc. (373110)의 EPS
2026 기준 EPS TTM: 0
Xcell Therapeutics, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Xcell Therapeutics, Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE